Chitosan

Phase 3Small molecule

UUniversity Hospital, Basel, Switzerland

Chitosan is one of 115 small molecule programs targeting Cancer Pain. It is currently in Phase 3.

Indications

Total Trials

Active Trials

114

Competitors

Pipeline

Status by Indication[3][1]

Indication

Cancer PainActive, not recruiting

Prostate CancerActive, not recruiting

AsthmaActive, not recruiting

Diabetic FootActive, not recruiting

Cancer PainPhase 3

Active, not recruiting

Prostate CancerPhase 1/Phase 2

Active, not recruiting

AsthmaPhase 1

Active, not recruiting

Diabetic FootPhase 3

Active, not recruiting

Competition

Competitive Landscape

1399 competitors in Prostate Cancer

#DrugCompanyPhaseTrials

Chitosan

UUniversity Hospital, Basel, Switzerland

Phase 3

1 2

Mekinist

Novartis

Preclinical

3 3

Jatenzo

GGrupo Espanol de Tumores Neuroendocrinos

Preclinical

2 4

Viagra

VViatris Specialty LLC

Preclinical

1 5

Duragesic

CCephalon

Preclinical

1 6

Ranexa

MMenarini International Operations Luxembourg SA

Preclinical

1 7

Osmitrol

BB. Braun Medical Inc.

Preclinical

—8

Ifex

BBaxter Healthcare Corporation

Preclinical

—9

Xylocaine

CCitius Pharmaceuticals, Inc.

Preclinical

—10

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Preclinical

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Tranexamic Acid1 trial

Comparison of Chitosan, Ankaferd and Tranexamic Acid in Dental Extraction in Liver Pre-Transplant Children

Completed·—·Phase 1·NCT06457360·39 enrolled

Cancer Pain1 trial

Comparison of Oral Morphine Versus Nasal Ketamine Spray With Chitosan in Cancer Pain Outpatients

Terminated·UUniversity Hospital, Basel, Switzerland·Phase 3·NCT02591017·11 enrolled

Nanoparticle1 trial

The Anti-fungal Effect of Miconazol Versus Miconazol-Loaded Chitosan Nanoparticles

Completed·YYasmine gamil·Phase 1·NCT06072716·80 enrolled

Diabetic Foot1 trial

Efficacy of the Combination of Isosorbide Dinitrate Spray and Chitosan in Diabetic Foot Ulcers

Completed·UUniversity of Guadalajara·Phase 3·NCT02789033·68 enrolled

Fallopian Tube1 trial

Effect of Shockwaves on Fallopian Tubes Adhesion

Not yet recruiting·—·N/A·NCT06755528·40 enrolled

7 more indications

Chlorhexidine1 trial

Chitosan,Chitosan Nanoparticles,and Chlorhexidine Gluconate, as Intra Canal Medicaments in Primary Teeth

Unknown status·—·N/A·NCT03588351·45 enrolled

Osseointegration1 trial

Effectiveness of Hydroxyapatite Reinforced Chitosan Hydrogel in Modulation of Osseointegration

Completed·MMinia University·N/A·NCT06758440·20 enrolled

Calcium Hydroxide1 trial

Effect of Using Nanochitosan Versus Calcium Hydroxide as Disinfectant on Pain and Apical Bone Healing

Unknown status·—·N/A·NCT03724266·60 enrolled

Asthma1 trial

Clinical Assessment of Chitosan Nanoparticles on Periodontal Problems Post Steroidal Inhalation in Asthmatic Patients: Phase I Trial

Completed·—·Phase 1·NCT06525363·20 enrolled

Pediatric Patients1 trial

A Crossover Clinical Study to Evaluate the Effect of Chitosan Mouthwash on Recurrence of Black Stains in Pediatric Patients

Recruiting·—·N/A·NCT06714695·17 enrolled

Prostate Cancer1 trial

Study of Chitosan for Pharmacologic Manipulation of AGE Levels in Prostate Cancer Patients

Terminated·MMedical University of South Carolina·Phase 1/2·NCT03712371·12 enrolled

Surgical1 trial

Use of Chitosan Powder in Loop Electrosurgical Excision Procedure

Completed·EErzincan Military Hospital·Phase 4·NCT05661708·130 enrolled

Sources

References

[1]
ClinicalTrials.gov — 12 trial records for Chitosan. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Chitosan compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Chitosan. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University Hospital, Basel, Switzerland company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: UUniversity Hospital, Basel, Switzerland

Chitosan

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Tranexamic Acid1 trial

Cancer Pain1 trial

Nanoparticle1 trial

Diabetic Foot1 trial

Fallopian Tube1 trial

Chlorhexidine1 trial

Osseointegration1 trial

Calcium Hydroxide1 trial

Asthma1 trial

Pediatric Patients1 trial

Prostate Cancer1 trial

Surgical1 trial

References

Drug Info

Quick Facts

Related News